Omicia's world-class biologists, geneticists, genomic scientists, and physicians are collaborating on new applications and services to lead the transformation of genetically-informed healthcare. The dramatically declining cost of DNA sequencing and genotyping has resulted in an information-processing bottleneck that limits the potential use of genomic information to improve predictive and preventive medical care. Omicia's flexible bioinformatics platform helps to overcome the bottleneck and unlock the potential applications of this information.

Our software platform can be used by scientists to help design experiments; by clinicians to develop diagnostic DNA tests using technologies such as microarrays and molecular diagnostics; and by physicians to help interpret the results of genetic tests and use the results to provide better individualized healthcare.

One of our pilot projects, the Disease Marker Genome Annotation System, extracts information from databases that catalog genetic variations, such as the Online Mendelian Inheritance in Man (OMIM) database, in order to computationally map clinical disease information directly onto the human genome sequence. With this software, Omicia has already succeeded in linking more human genes to disease phenotypes than any previously published approach.

On May 9, 2007, Omicia presented a poster about the OMIM mapping project at the 2007 Cold Spring Harbor Laboratory Conference on "The Biology of Genomes": Disease-Predisposition Alleles in the Human Genome.